The use of the vaccine, branded Spikevax, will be the same in children from 12 to 17 years as in people aged 18 and above, the European Medicines Agency (EMA) said.
EU regulator endorses use of Moderna COVID-19 vaccine in teens
By REUTERS
03/02/2025 07:37 PM
By REUTERS
03/02/2025 07:34 PM
By REUTERS
03/02/2025 05:56 PM
By REUTERS
03/02/2025 05:53 PM
By REUTERS
03/02/2025 02:49 PM
By REUTERS
03/02/2025 12:46 PM